Mesenchymal stem/stromal cells (MSCs) are stromal-derived non-hematopoietic progenitor ... adipose tissue, amniotic fluid, placenta, dental pulp and skin. The discovery of the immunosuppressing action ...

Mesenchymal stem cells (MSCs), or mesenchymal stromal cells ... have utilized the experimental autoimmune encephalomyelitis (EAE) murine model of MS to show that human placental MSC (hP-MSC)-derived ...

Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long ...

The novel drug CT-179 ... How Healthy Stem Cells Turn Into Oral Cancer Feb. 4, 2025 — Researchers have identified the molecular and cellular mechanisms that transform healthy stem cells into ...

More information: Barbara Klein et al, Modified human mesenchymal stromal/stem cells restore cortical excitability after focal ischemic stroke in rats, Molecular Therapy (2024). DOI: 10.1016/j.ymthe.

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Food and Drug Administration (FDA) approved the first mesenchymal stromal cell (MSC) therapy, RYONCIL®, indicated for steroid-refractory acute graft ...

The placental progenitor stem cell is the cytotrophoblast cell. These cells are responsible for the cellular growth of the placenta, and they have the ability to proliferate and differentiate ...

Marshall Davies was told in December he would need a stem cell transplant One hundred people have signed up to the stem cell register to see if they are a match for a man who has blood cancer.